Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women

2017 ◽  
Vol 45 (12) ◽  
pp. 1065-1072
Author(s):  
Rosario Granados ◽  
Hilda Tellez-Safina ◽  
Isabel Solis ◽  
Francisco Mateos ◽  
Jose Maria Rodriguez-Barbero ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Young Women ◽  
Hpv E6

scholarly journals The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China

2020 ◽  
Vol 10 ◽  
Author(s):  
Shao-Kai Zhang ◽  
Zhen Guo ◽  
Peng Wang ◽  
Le-Ni Kang ◽  
Man-Man Jia ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Hpv E6 ◽  
Potential Benefits

scholarly journals Confusion regarding cervical cancer screening and chlamydia screening among sexually active young women: Table 1

2011 ◽  
Vol 88 (1) ◽  
pp. 35-37 ◽  
Author(s):  
Oluwatobi Awele Ogbechie ◽  
Michele R Hacker ◽  
Laura E Dodge ◽  
Mitalee Milan Patil ◽  
Hope A Ricciotti
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Young Women ◽  
Chlamydia Screening ◽  
Sexually Active

scholarly journals Cervical cancer screening varies by HPV vaccination status among a National Cohort of privately insured young women in the United States 2006–2016

Medicine ◽  
2021 ◽  
Vol 100 (41) ◽  
pp. e27457
Author(s):  
Djibril M. Ba ◽  
Jennifer S. McCall-Hosenfeld ◽  
Paddy Ssentongo ◽  
Vernon M. Chinchilli ◽  
Edeanya Agbese ◽  
...  
Keyword(s):  
United States ◽  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Young Women ◽  
Hpv Vaccination ◽  
The United States ◽  
Vaccination Status ◽  
National Cohort ◽  
Privately Insured

scholarly journals Young women’s knowledge and attitudes towards cervical cancer screening at a selected higher education institution in Lesotho: a cross-sectional survey

2021 ◽  
Author(s):  
Isabel Nyangu ◽  
Tanki Moteane
Keyword(s):  
Higher Education ◽  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Young Women ◽  
Education Institution ◽  
Cross Sectional Survey ◽  
Higher Education Institution ◽  
Cross Sectional ◽  
Knowledge And Attitudes

Abstract Background In Lesotho, cervical cancer is the most common female cancer and leading cause of death amongst women. In 2019, the annual number of new cancer cases was 477 and 346 women died from cancer related complications in Lesotho. The aim of this study was to assess the knowledge and attitudes of young women towards cervical cancer screening at a selected higher education institution in Lesotho. Methods A quantitative cross-sectional survey design was used to collect data using an interviewer administered semi-structured questionnaire from 80 young women. Random sampling using a fishbowl technique was used to select study respondents. Permission to conduct the study was sought and granted from relevant authorities. Informed consent was sought from the respondents who were identified using codes and participated voluntarily. Data were analysed using Microsoft excel and presented using proportions and diagrams. Results Fifty percent (n=40) of the women did not know cervical cancer screening tests, 70% (n=56) did not know about the frequency of screening, whilst 75% (n=60) knew that human papilloma virus (HPV) vaccine is used to prevent cervical cancer. Additionally, 95% (n=76) had not screened for cervical cancer, 65% (n=52) perceived cervical cancer screening as painful, 35% (n=28) said it caused discomfort, and 95% (n=76) needed more information on cervical cancer screening. Conclusions Even though some respondents had knowledge on cervical cancer and its prevention, the uptake of the screening procedure was low. Negative experiences of pain and discomfort were reported amongst those who had the procedure done. This heightens the need for health education and incorporating regular cervical cancer screening in health care services to increase reassurance, counselling, and the uptake of the procedure amongst young women.

Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening

2020 ◽  
Vol 158 (3) ◽  
pp. 590-596
Author(s):  
Rifat Ara ◽  
Sabera Khatun ◽  
Shahana Pervin ◽  
Munira Jahan ◽  
Umme Shahera ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Human Papilloma Virus ◽  
Cervical Cancer Screening ◽  
Molecular Biomarker ◽  
Papilloma Virus ◽  
Hpv E6 ◽  
E6 Oncoprotein
Sign in / Sign up

Export Citation Format

Share Document